533 related articles for article (PubMed ID: 25613538)
21. Human Biodistribution and Radiation Dosimetry of S-11C-Methyl-L-Cysteine Using Whole-Body PET.
Yao B; Tang C; Tang G; Hu K; Liang X; Shi X; Nie D; Tang X; Yue D
Clin Nucl Med; 2015 Oct; 40(10):e470-4. PubMed ID: 25742235
[TBL] [Abstract][Full Text] [Related]
22. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
[TBL] [Abstract][Full Text] [Related]
23. Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET.
Laforest R; Dehdashti F; Lewis JS; Schwarz SW
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):764-70. PubMed ID: 15785955
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice.
Constantinescu CC; Sevrioukov E; Garcia A; Pan ML; Mukherjee J
Mol Imaging Biol; 2013 Apr; 15(2):222-9. PubMed ID: 22833323
[TBL] [Abstract][Full Text] [Related]
25. Human radiation dose estimation of (11)C-CFT using whole-body PET.
Huang T; Wang H; Tang G; Liang X; Deng H; Yi C; Zhang X
Clin Nucl Med; 2012 Dec; 37(12):1159-62. PubMed ID: 23154473
[TBL] [Abstract][Full Text] [Related]
26. High-dose radioimmunotherapy with 90Y-ibritumomab tiuxetan: comparative dosimetric study for tailored treatment.
Cremonesi M; Ferrari M; Grana CM; Vanazzi A; Stabin M; Bartolomei M; Papi S; Prisco G; Ferrucci PF; Martinelli G; Paganelli G
J Nucl Med; 2007 Nov; 48(11):1871-9. PubMed ID: 17978355
[TBL] [Abstract][Full Text] [Related]
27. Radiation Dosimetry and Biodistribution of
Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J
J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685
[TBL] [Abstract][Full Text] [Related]
28. Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients.
Sandström M; Lindskog K; Velikyan I; Wennborg A; Feldwisch J; Sandberg D; Tolmachev V; Orlova A; Sörensen J; Carlsson J; Lindman H; Lubberink M
J Nucl Med; 2016 Jun; 57(6):867-71. PubMed ID: 26912439
[TBL] [Abstract][Full Text] [Related]
29. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.
Obrzut SL; Koren AO; Mandelkern MA; Brody AL; Hoh CK; London ED
Nucl Med Biol; 2005 Nov; 32(8):869-74. PubMed ID: 16253812
[TBL] [Abstract][Full Text] [Related]
30. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
Quinn B; Dauer Z; Pandit-Taskar N; Schoder H; Dauer LT
BMC Med Imaging; 2016 Jun; 16(1):41. PubMed ID: 27317478
[TBL] [Abstract][Full Text] [Related]
31. Estimation of radiation dose to patients from (18) FDG whole body PET/CT investigations using dynamic PET scan protocol.
Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mondal A; Mishra AK; Dwarakanath BS
Indian J Med Res; 2015 Dec; 142(6):721-31. PubMed ID: 26831421
[TBL] [Abstract][Full Text] [Related]
32. Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.
Challapalli A; Sharma R; Hallett WA; Kozlowski K; Carroll L; Brickute D; Twyman F; Al-Nahhas A; Aboagye EO
J Nucl Med; 2014 Feb; 55(2):256-63. PubMed ID: 24492392
[TBL] [Abstract][Full Text] [Related]
33. First Evaluation of PET-Based Human Biodistribution and Dosimetry of
Savi A; Incerti E; Fallanca F; Bettinardi V; Rossetti F; Monterisi C; Compierchio A; Negri G; Zannini P; Gianolli L; Picchio M
J Nucl Med; 2017 Aug; 58(8):1224-1229. PubMed ID: 28209906
[No Abstract] [Full Text] [Related]
34. Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings.
Behr TM; Béhé M; Sgouros G
Cancer Biother Radiopharm; 2002 Aug; 17(4):445-64. PubMed ID: 12396708
[TBL] [Abstract][Full Text] [Related]
35. PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans.
Liu N; Li M; Li X; Meng X; Yang G; Zhao S; Yang Y; Ma L; Fu Z; Yu J
J Nucl Med; 2009 Feb; 50(2):303-8. PubMed ID: 19164239
[TBL] [Abstract][Full Text] [Related]
36. Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy.
Ferrer L; Kraeber-Bodéré F; Bodet-Milin C; Rousseau C; Le Gouill S; Wegener WA; Goldenberg DM; Bardiès M
Cancer; 2010 Feb; 116(4 Suppl):1093-100. PubMed ID: 20127958
[TBL] [Abstract][Full Text] [Related]
37. 1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.
Virta JR; Tolvanen T; Någren K; Brück A; Roivainen A; Rinne JO
J Nucl Med; 2008 Mar; 49(3):347-53. PubMed ID: 18287260
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.
Postema EJ; Börjesson PK; Buijs WC; Roos JC; Marres HA; Boerman OC; de Bree R; Lang M; Munzert G; van Dongen GA; Oyen WJ
J Nucl Med; 2003 Oct; 44(10):1690-9. PubMed ID: 14530488
[TBL] [Abstract][Full Text] [Related]
39. Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand 11C-CNS5161.
Dhawan V; Robeson W; Bjelke D; Chaly T; Graf K; Hellman M; Zhuo L; Mackay M; Eidelberg D
J Nucl Med; 2015 Jun; 56(6):869-72. PubMed ID: 25931480
[TBL] [Abstract][Full Text] [Related]
40. Phase I study to assess safety, biodistribution and radiation dosimetry for
Merkx RIJ; Lobeek D; Konijnenberg M; Jiménez-Franco LD; Kluge A; Oosterwijk E; Mulders PFA; Rijpkema M
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3277-3285. PubMed ID: 33651116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
